Returns | 1W : -4.8% , 1M : 7.1%,1Y : 47.3% |
LT :   |
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : Low |
ST :   |
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward Pledged Shares : Average [>25% and <50%] |
Peers & Returns | 1W | 1M | 1Y |
NATH BIOGENES (INDIA) | -4.8% | 7.1% | 47.3% |
BOMBAY BURMAH TRADING CORPORATION | -4% | -1% | 37.9% |
KAVERI SEED COMPANY | 8.2% | 15.6% | 51.5% |
VENKYS (INDIA) | -2.7% | -4% | 32.7% |
GOODRICKE GROUP | 0.5% | -10.4% | 37% |
JK AGRI GENETICS | -5.4% | 2.6% | 35.5% |
SHREE GANESH BIOTECH (INDIA) | -0.7% | -0.7% | -27.4% |
DHUNSERI TEA & INDUSTRIES | 0.5% | -7% | 81% |
HARRISONS MALAYALAM | -0.5% | -10% | 130.3% |
Ratio | Value |
---|---|
P/E P/B P/S |
12.12
P/E Calculated based on EPS of 26.56
[ Mar2020 - Standalone Results ] 1.1
P/B Calculated based on Book Value of 293.42
[ Mar2020 - Standalone Results ] 1.98
P/S Calculated based on Revenues of 309.031 Cr
[ TTM - Standalone Results ] |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
56% 52% 96% |
Pledged Shares |
36.31 % |
---|---|
As on : Sep2020 | |
If less than 25% | Good |
If between 25% and 50% | Neutral |
If greater than 50% | Bad |
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | -0.1% | 0.3% | 91.4% |
S&P BSE MIDSMALLCAP | -0.3% | -0.3% | 79.7% |
S&P BSE ALLCAP | -1.1% | -2.1% | 60% |
S&P BSE FMCG | -1.3% | 3.5% | 16.1% |